Lifeward (LFWD) vs PAVmed (PAVM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lifeward (LFWD) has outperformed PAVmed (PAVM) over the past year, losing 35.3% versus a loss of 81.1%. Over five years, LFWD leads with a -94.4% price change compared with -99.9% for PAVM. PAVmed is the larger company by market cap ($21.5 million vs $18.2 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LFWD | PAVM |
|---|---|---|
| Share price | $6.43 | $2.69 |
| Market cap | $18.21M | $21.51M |
| 1-day change | -1.08% | -1.82% |
| YTD return | -7.13% | -59.43% |
| 1-year return | -35.29% | -81.12% |
| 5-year return | -94.37% | -99.90% |
| EPS (TTM) | $-15.73 | $-14.20 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $9.84 | $28.44 |
| 52-week low | $4.14 | $2.60 |
| Distance from 52-week high | -34.65% | -90.54% |
| Analyst consensus | none | none |
| Avg. price target upside | +211.04% | +1256.88% |
| Average volume | 6.08K | 30.34K |
| Shares outstanding | 2.83M | 8.00M |
| Employees | 81 | 41 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFWD has outperformed PAVM by 45.8 percentage points over the past year.
About Lifeward
LFWD stock →Lifeward Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, Germany, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices for individuals with spinal cord injury; ReStore Exo-Suit, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals' post-stroke.
Healthcare · Medical Devices · 81 employees
About PAVmed
PAVM stock →PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States.
Healthcare · Medical Devices · 41 employees
LFWD vs PAVM FAQ
Which is bigger, Lifeward or PAVmed?
PAVmed (PAVM) is larger, with a market capitalization of $21.51M compared with $18.21M for Lifeward (LFWD).
Which stock has performed better over the past year, LFWD or PAVM?
LFWD returned -35.29% over the past 12 months, compared with -81.12% for PAVM (price return, excluding dividends). Past performance does not predict future results.
Are Lifeward and PAVmed in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.